Wu Yanan, Fenfen E, Wang Yan, Xu Meng, Liu Simin, Zhou Liying, Song Guihang, Shang Xue, Yang Chaoqun, Yang Kehu, Li Xiuxia
Health Technology Assessment Center/Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Internet Interv. 2023 Sep 30;34:100673. doi: 10.1016/j.invent.2023.100673. eCollection 2023 Dec.
Internet-based cognitive behavior therapy (ICBT) may provide an accessible alternative to face-to-face treatment, but the evidence base in adolescents is limited. This systematic review and meta-analysis aims to comprehensively assess the efficacy of ICBT in addressing depression among adolescents.
Four electronic databases were searched on June 8, 2023. Randomized controlled trials (RCTs) evaluating the efficacy of ICBT for depression in adolescents were included. The quality of the studies was assessed using the risk of bias tool recommended by the Cochrane Handbook. Furthermore, the GRADE approach was employed to gauge the certainty of the obtained evidence. Meta-analysis was conducted using RevMan 5.4, and Egger's test was implemented through Stata for assessment of potential publication bias.
A total of 18 RCTs involving 1683 patients were included. In comparison to control groups like attention control, waiting list, and treatment as usual, our meta-analysis findings elucidate a significant reduction in depression scores (SMD = -0.42, 95 % CI: [-0.74, -0.11], < .05) as well as anxiety scores (SMD = -0.34, 95 % CI: [-0.60, -0.08], < .05) in adolescents following ICBT interventions. Furthermore, the analysis indicated no notable distinctions in patient's quality of life (QoL) scores. (SMD = 0.12, 95 % CI: [-0.10, 0.34], > .05).
Results provide evidence of the efficacy of ICBT to reduce depressive and anxiety symptoms in adolescents. These research findings are of vital significance for the establishment of evidence-based treatment guidelines in the digital era.
PROSPERO registration: CRD42021277562.
基于互联网的认知行为疗法(ICBT)可能为面对面治疗提供一种可及的替代方案,但青少年群体的证据基础有限。本系统评价和荟萃分析旨在全面评估ICBT治疗青少年抑郁症的疗效。
于2023年6月8日检索了四个电子数据库。纳入评估ICBT治疗青少年抑郁症疗效的随机对照试验(RCT)。使用Cochrane手册推荐的偏倚风险工具评估研究质量。此外,采用GRADE方法评估所得证据的确定性。使用RevMan 5.4进行荟萃分析,并通过Stata实施Egger检验以评估潜在的发表偏倚。
共纳入18项RCT,涉及1683例患者。与注意力控制、等待名单和常规治疗等对照组相比,我们的荟萃分析结果表明,ICBT干预后青少年的抑郁评分(标准化均数差[SMD]= -0.42,95%置信区间:[-0.74,-0.11],P<0.05)以及焦虑评分(SMD = -0.34,95%置信区间:[-0.60,-0.08],P<0.05)显著降低。此外,分析表明患者的生活质量(QoL)评分无显著差异(SMD = 0.12,95%置信区间:[-0.10,0.34],P>0.05)。
结果提供了ICBT减轻青少年抑郁和焦虑症状疗效的证据。这些研究结果对于数字时代基于证据的治疗指南的制定具有至关重要的意义。
PROSPERO注册编号:CRD42021277562。